醫師介紹

Doctor Introduction

:::

個人介紹

Mei-chih Chen
Mei-chih Chen

副研究員

陳美智 Mei-chih Chen

副研究員
生理學、內分泌學、癌症生物學、細胞生物學
相關連結
學術論文

期刊論文

期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
日期
1 高暐翔(KAO WEI-HSIANG)、(Kun-Yuan Chiu)、(Stella Chin-Shaw Tsai)、(Chieh-Lin Jerry Teng)、(Muhammet Oner)、(Chih-Ho Lai)、(Jer-Tsong Hsieh)、(Chi-Chien Lin)、(Hsin-Yi Wang)、陳美智(CHEN MEI-CHIH)*、(Ho Lin)*,PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation,BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,2025 Feb,1871(2):1676568 2025 . 02
2 林彥宏、(Chen Y)、劉恩瑋(En-Wei Liu)、陳美智(CHEN MEI-CHIH)、余旻樺(YU MIN-HUA)、陳正祐(CHEN CHENG-YU)、(Ho CC)、許姜太懿(Xu-Jiang,Tai-Yi)、李建智(LEE JIAN-JR)*、周德陽(Der-Yang Cho)*、謝明佑(Ming-You Shie)*,Immunomodulation effects of collagen hydrogel encapsulating extracellular vesicles derived from calcium silicate stimulated-adipose mesenchymal stem cells for diabetic healing,JOURNAL OF NANOBIOTECHNOLOGY,2025 Jan,23():45 2025 . 01
3 林育全(Yu-Chuan Lin)、陳美智(CHEN MEI-CHIH)、黃士維(Shi-Wei Huang)、陳曄(Yeh Chen)、何慧君(HO HUI-CHUN)、林芳妤(Fang-Yu Lin)、陳筱彤(TAN XIAO TONG)、江宏哲(Hung Che Chiang)、黃秋錦(Chiu-Ching Huang)、涂智彥(Chih-Yen Tu)、周德陽(Der-Yang Cho)*、邱紹智(Shao-Chih Chiu)*,Targeting Dual Immune Checkpoints PD-L1 and HLA-G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer,Advanced Science,2024 Sep,2024(Sep 5): 2024 . 09
4 (Muhammet Oner)、陳美智(CHEN MEI-CHIH)、(Pang-Ting Cheng)、(Ho Lin)*,Metformin inhibits nerve growth factor (NGF)-induced sympathetic neuron differentiation through p35/CDK5 inhibition,AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY,2024 Jun,326(6):C1648-C1658 2024 . 06
5 (Muhammet Oner)、陳美智(CHEN MEI-CHIH)、(Pang-Ting Cheng)、黎喻暄(Li, Yu-Hsuan)、(Yu-Chiao Cheng)、(Ayse Celik)、(Shiuan-Woei Soong)、(Li-Wen Hsu)、(Din-You Lin)、(G.M. Shazzad Hossain Prince)、(Trayee Dhar)、(Hsu-Chen Cheng)、(Pin-Chi Tang)、(Ho Lin)*,Impact of metformin on neocortical development during pregnancy: Involvement of ERK and p35/CDK5 pathways,Chemosphere,2024 Apr,358(2024):142124 2024 . 04
6 (Muhammet Oner)、(Pang-Ting Cheng)、(Hsin-Yi Wang)、陳美智(CHEN MEI-CHIH)、(Ho Lin)*,Metformin alters dendrite development and synaptic plasticity in rat cortical neurons,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2024 Mar,710(2024):149874 2024 . 03
7 (Muhammet Oner)、(Eugene Lin)、(Kun-Yuan Chiu)、陳美智(CHEN MEI-CHIH)、(G. M. SHAZZAD HOSSAIN PRINCE)、(CHIH-HO LAI)、(JER-TSONG HSIEH)、(HSIN-YI WANG)、(HO LIN)*,p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer,ANTICANCER RESEARCH,2024 Feb,44(2):543-553 2024 . 02
8 (Chieh-Lin Jerry Teng)、(Pang-Ting Cheng)、(Yu-Chiao Cheng)、(Jia-Rung Tsai)、陳美智(CHEN MEI-CHIH)、(Ho Lin)*,Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways,TOXICOLOGY IN VITRO,2024 Jan,(96): 2024 . 01
9 (Liao, Wan-Ling)、(Ho Lin)、黎喻暄(Li, Yu-Hsuan)、(Tsung-Ying Yang)、陳美智(CHEN MEI-CHIH)*,RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells,AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY,2023 Sep,2023(): 2023 . 09
10 黃士維、潘志明(Chih-Ming Pan)、林育全、陳美智(CHEN MEI-CHIH)、陳曄、詹佳穎、吳仲峻(WU CHUNG CHUN)、林芳妤(Fang-Yu Lin)、王馨葶、林宸宇(Chen-Yu Lin)、林佩瑩(LIN PEI-YING)、黃偉翔、蔣郁亭(Chiang, Yu-Ting)、蔡宛臻(Wan-Chen Tsai)、邱雅煦(CHIU YA-HSU)、林庭熏(Ting-Hsun, Lin)、邱紹智(Shao-Chih Chiu)*、周德陽(Der-Yang Cho)*,BiTE-secreting CAR-γδT as a dual targeting strategy for the treatment of solid tumors,Advanced Science,2023 Jun,10(17):e2206856. 2023 . 06
11 陳美智(CHEN MEI-CHIH)、洪孟愉、潘志明(Chih-Ming Pan)、黃士維(Shi-Wei Huang)、詹佳穎(Chia-Ing Jan)、黎喻暄(Li, Yu-Hsuan)、邱紹智(Shao-Chih Chiu)*、周德陽(Der-Yang Cho)*,Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer,CANCER SCIENCE,2023 Apr,(): 2023 . 04
12 陳美智(CHEN MEI-CHIH)、(Bing-Ze Yang)、郭薇雯(Kuo, Wei-Wen)、吳世欣(Wu, Shih-Hsin)、(Tso-Fu Wang)、(Yu-Lan Yeh)、(Ming-Cheng Chen)*、黃志揚(Chih-Yang Huang)*,The involvement of Aurora-A and p53 in oxaliplatin-resistant colon cancer cells,JOURNAL OF CELLULAR BIOCHEMISTRY,2023 Mar,2023():1-14 2023 . 03
13 (Chieh-Yin Chen)、黎喻暄(Li, Yu-Hsuan)、(Wan-Ling Liao)、(Muhammet Oner)、(Yu-Chiao Cheng)、(Fang-Ling Liu)、(Pang-Ting Cheng)、(Ayse Celik)、(Jyh-Horng Wu)、(Chih-Ho Lai)、(Jer-Tsong Hsieh)、(Ho Lin)、(Ting-Chieh Chang)、(Chih-Ying Chang)、陳美智(CHEN MEI-CHIH)*,Antrodia salmonea extracts regulate p53-AR signaling and apoptosis in human prostate cancer LNCaP cells,Evidence-based Complementary and Alternative Medicine,2022 Nov,2022(): 2022 . 11
14 (Pang-Ting Cheng)、(Yu-Chiao Cheng)、(Muhammet Oner)、(Yu-Hsuan Li)、陳美智(CHEN MEI-CHIH)、(Jyh-Horng Wu)、(Ting-Chieh Chang)、(Ayse Celik)、(Fang-Ling Liu)、(Hsin-Yi Wang)、(Hsin-Yi Wang)、(Jer-Tsong Hsieh)、(Chieh-Yin Chen)*、(Ho Lin)*,Antrodia salmonea Extract Inhibits Cell Proliferation through Regulating Cell Cycle Arrest and Apoptosis in Prostate Cancer Cell Lines.,CHINESE JOURNAL OF PHYSIOLOGY,2022 Aug,65(4):209-214 2022 . 08
15 (Chia-Herng Yue)、(Muhammet Oner)、(Chih-Yuan Chiu)、陳美智(CHEN MEI-CHIH)、(Chieh-Lin Teng)、(Hsin-Yi Wang)、(Jer-Tsong Hsieh)、(Chih-Ho Lai)、(Ho Lin)*,RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation,Biomolecules,2021 Jun,2021(11):860 2021 . 06
16 (Ming?Cheng Chen)、(Do Chi Nhan)、(Chiung?Hung Hsu)、(Tso?Fu Wang)、(Chi?Cheng Li)、(Tsung?Jung Ho)、(B. Mahalakshmi)、陳美智(CHEN MEI-CHIH)*、楊良友(Liang-Yo Yang)*、黃志揚(Chih-Yang Huang)*,SENP1 participates in Irinotecan resistance in human colon cancer cells,JOURNAL OF CELLULAR BIOCHEMISTRY,2021 May,(): 2021 . 05
17 (Wei-Chung Hsu)、(Hang-Nga Le)、(Yu-Jung Lin)、(Ming-Cheng Chen)、(Tso-Fu Wang)、(Chi-Cheng Li)、郭薇雯(Wei-Wen Kuo)、(B Mahalakshmi)、(Chaouhan Hitesh Singh)、陳美智(CHEN MEI-CHIH)*、黃志揚(Chih-Yang Huang)*,Calmodulin/CaMKII-γ mediates prosurvival capability in apicidin-persistent hepatocellular carcinoma cells via ERK1/2/CREB/c-fos signaling pathway,JOURNAL OF CELLULAR BIOCHEMISTRY,2021 Jan,2021():1-14 2021 . 01
18 陳美智(CHEN MEI-CHIH)、(Kun-Chieh Chen)、(Gee-Chen Chang)、(Ho Lin)、(Chun-Chi Wu)、(Wei-Hsiang Kao)、(Chieh-Lin Jerry Teng)、(Shih-Lan Hsu)、(Tsung-Ying Yang)*,RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer,Cell Death & Disease,2020 Apr,11(4):265 2020 . 04
19 (G. M. Shazzad Hossain Prince)、(Tsung?Ying Yang)、(Ho Lin1)*、陳美智(CHEN MEI-CHIH)*,Mechanistic Insight of Cyclin‑Dependent Kinase 5 in Modulating Lung Cancer Growth,CHINESE JOURNAL OF PHYSIOLOGY,2019 Nov,62(6):231-240 2019 . 11
20 (Muhammet Oner)、林育慶(Eugene Lin)、陳美智(CHEN MEI-CHIH)、許馥甯(Fu-Ning Hsu)、(G M Shazzad Hossain Prince)、裘坤元(Kun-Yuan Chiu)、騰傑林(Chieh-Lin Jerry Teng)、楊宗穎(Tsung-Ying Yang)、王欣怡(Hsin-Yi Wang)、余長澤(Chia-Herng Yue)、余家珩(Ching-Han Yu)、賴志和(Chih-Ho Lai)、謝哲宗(Jer-Tsong Hsieh)、林赫(Ho Lin)*,Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Aug,20(16): 2019 . 08
21 傅建堯(Fu, Chien-Yao)、陳美智(CHEN MEI-CHIH)、(Yan-Shen Tseng)、(Ming-Cheng Chen)、(Zhengtao Zhou)、(Jaw-Ji Yang)、(Yueh-Min Lin)、(Vijaya P. Viswanadha)、(Guiqing Wang)、黃志揚(Chih-Yang Huang)*,Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression,ENVIRONMENTAL TOXICOLOGY,2019 May,(): 2019 . 05
22 (Chih-Hsiang Chang)、陳美智(CHEN MEI-CHIH)、(Te-Huan Chiu)、(Yu-Hsuan Li)、(Wan-Chen Yu)、(Wan-Ling Liao)、(Muhammet Oner)、(Chang-Tze Ricky Yu)、(Chun-Chi Wu)、(Tsung-Ying Yang)、(Chieh-Lin Jerry Teng)、(Kun-Yuan Chiu)、(Kun-Chien Chen)、(Hsin-Yi Wang)、(Chia-Herng Yue)、(Chih-Ho Lai)、(Jer-Tsong Hsieh)、(Ho Lin)*,Arecoline Promotes Migration of A549 Lung Cancer Cells through Activating the EGFR/Src/FAK Pathway,Toxins,2019 Apr,11(4): 2019 . 04

研討會論文

研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
日期
1 Exemestane inhibits survival and cell cycle regulators and retards AML cell proliferation,2023 AACR Special Conference: AML and Myelodysplastic Syndrome,Hyatt Regency Austin in Austin, TX.,2023.01.23~2023.01.25, 2023 . 01
2 Regulation of protein level and subcellular localization of p53 and Aurora A upon UVC treatment in LNCaP cells,第36屆生物醫學聯合學術年會The 36th Joint Annual Conference of Biochemical Science,Taipei, Taiwan.,2022.03.26~2022.03.27, 2022 . 03
3 Detecting suspended A549 lung cancer cells by 3D hollow SERS active magnetic nanoparticles using cell surface RAGE protein as a target.,第36屆生物醫學聯合學術年會The 36th Joint Annual Conference of Biochemical Science, Taipei, Taiwan.,Taipei, Taiwan.,2022.03.26~2022.03.27, 2022 . 03
4 The effects of ultraviolet c on the regulation of Aurora A and p53 proteins in prostate cancer LNCaP cells,The 1st International Electronic Conference on Cancers,online,2021.02.1 ~2021.02.14, 2021 . 02
5 The effects of Antrodia salmonea extracts on androgen receptor inhibition and LNCaP cell apoptosis,The 1st International Electronic Conference on Toxins,online,2021.01.16~2021.01.31, 2021 . 01
6 CDK5 down-regulates p21expression through inhibiting STAT3,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
7 CaM upregulation in HDACi-resistant cells activates multiple downstream protein promote cell resist to drug in Hepatocellular carcinoma cells,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, 2019 . 03
8 IL-6 promotes CDK5-induced STAT3/androgen receptor activation in prostate cancer cells,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
9 The inhibitory effects of microRNA-107 on p35/CDK5-regulated prostate cancer cell growth,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
10 CDK5 regulates estrogen receptor and breast cancer cell growth,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
11 CDK5 promotes androgen receptor transactivation under Akt inhibition stress,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
12 Dinaciclib inhibits Aurora A expression and proliferation of prostate cancer cells.,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
13 The inhibitory effects of valproic acid on androgen receptor and prostate cancer cell growth,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
14 Synergistic inhibition of Dinaciclib and Paclitaxel on breast cancer cell growth,The 2019 Federation of the Asian and Oceanian Physiological Societies Congress,日本,2019.03.28~2019.03.31, 2019 . 03
15 The role of SUMO1 Specific Peptidase 1 in irinotecan resistant LoVo colorectal cancer cells,第34屆生物醫學聯合學術年會,國防醫學院,2019.03.23~2019.03.24, 2019 . 03
16 Synergistic effect of metformin and emodin on the stability and expression of androgen receptor protein in LNCaP,The 2018 annual meeting of Asia Pacific Society for Biology and Medical Sciences,日本,2018.07.19~2018.07.22, 2018 . 07

專書

暫無資料

研究計畫

研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間)
日期
1 個別型,MOST 110-2320-B-039-012-MY3,,科技部,探討RAGE對EGFR訊息路徑的調控及其交互作用對癌細胞的影響,2023.8.1~2024.7.31 2023 . 08
2 個別型,DMR-112-137,周德陽(Der-Yang Cho),附醫院內計畫,探討pemetrexed聯合抗PD-L1免疫檢查點阻斷對HLA-G-CAR-γδT細胞毒殺非小細胞肺癌的影響,2022.8.1~2023.7.31 2022 . 08
3 個別型,MOST 110-2320-B-039-012-MY3,,科技部,探討RAGE對EGFR訊息路徑的調控及其交互作用對癌細胞的影響,2022.8.1~2023.7.31 2022 . 08
4 個別型,MOST 110-2320-B-039-012-MY3,,科技部,探討RAGE對EGFR訊息路徑的調控及其交互作用對癌細胞的影響,2021.8.1~2022.7.31 2021 . 08
5 個別型,DMR-110-138,周德陽(Der-Yang Cho),附醫院內計畫,HLA-G作為特異性靶標嵌合抗原受體(CAR)工程T細胞療法用於治療非小型細胞肺癌的可行性,2020.8.1~2021.7.31 2020 . 08
6 個別型,CMU108-MF-92,,本校(含附醫),探討在Irinotecan 抗藥性大腸癌細胞中SUMO特異性蛋白酶1(SENP1)和SUMOylation調節HIF-1α的作用,2019.9.9~2020.7.31 2019 . 09
7 個別型,MOST 108-2320-B-039-008,黃志揚(Chih-Yang Huang),科技部,探討在Irinotecan 抗藥性大腸癌細胞中SUMO特異性蛋白酶1(SENP1)和SUMOylation調節HIF-1α的作用,2019.8.1~2020.7.31 2019 . 08
8 個別型,DMR-108-171,黃志揚(Chih-Yang Huang),附醫院內計畫,探討Aurora A在Dinaciclib抑制前列腺癌細胞生長中的作用,2018.8.1~2019.6.30 2018 . 08

專利技術

專利/Patent
(專利名稱,專利類別,專利國別,專利號碼,專利期間)
日期
1 FUSION PROTEINANDNUCLEICACID ENCODING SEQUENCETHEREOF,AND USES OFTHESAME,發明專利,美國、台灣、日本,US12221483B1,2024.1.30~2044.1.29 2024 . 01
2 多特異性單域抗體嵌合抗原受體及T細胞銜接體、核酸、其表達細胞、其用途以及治療癌症之醫藥組合物,發明專利,台灣,I823402,2023.11.21~2042.5.22 2023 . 11
3 IMMUNOMODULATIONAND ANTI-TUMOR-RELATEDNANOBODYAND NUCLEIC ACID ENCODING SEQUENCE THEREOF,AND USES OF THE SAME,發明專利,美國,US11795227B2,2023.10.24~2043.10.23 2023 . 10
4 抗腫瘤抗原奈米抗體暨其核酸編碼序列及其應用,發明專利,台灣,I799205,2023.4.11~2042.3.22 2023 . 04
5 抗-T細胞奈米抗體暨其核酸編碼序列及其應用,發明專利,台灣,I792955,2023.2.11~2042.3.22 2023 . 02
6 免疫調控奈米抗體暨其核酸編碼序列及其應用,發明專利,台灣,I790150,2023.1.11~2042.3.22 2023 . 01

獲獎事蹟

獲獎/Award
(獲獎名稱,給獎單位,獲獎日期)
日期
1 2023 未來科技獎,科技部,2023.10.14 2023 . 10

技術轉移

技術轉移/Technology Transfer
(技術名稱,發明人,合約期間,專利名稱,授權單位,授權單位名稱)
日期
1 雙特異性T細胞銜接奈米抗體治療平台,邱紹智(Shao-Chih Chiu)、周德陽(Der-Yang Cho)、黃士維、潘志明(Chih-Ming Pan)、陳美智(CHEN MEI-CHIH)、吳仲峻(WU CHUNG CHUN)、林育全,2021.7~2041.7,,本校(含附醫),聖安生醫股份有限公司 2021 . 07
至頂